• Page 14, line 21: How can this be a cluster if there are ‘only a few biotech ventures’?
Furthermore, ‘initial conditions’ fail to capture the complexity of clusters if they are reduced to a dichotomy of private vs. public sector dominance. Even when the industry (biotechnology) is held constant, clusters differ in a number of ways, esp. regarding their specialisation within biotechnology, their maturity, size (number of firms and employee) and firm size structure.